The Hans India: Cancer in Your Genes? ‘DNA Onco Screen’ Can Assess It
Originally published in The Hans India, February 22, 2019.
A section of the medical fraternity believes that if a person gets affected by any of the nearly 15 major types of cancers — including breast cancer, ovarian cancer, prostate cancer, and colorectal cancer — there are up to 10% chances that family members too would be affected at a later stage.
Family members of the affected patient could go for early detection through DNA Onco Screen, a state-of-the-art genetic testing procedure which assesses one’s DNA and biochemical profile. The report helps estimate one’s chance of developing cancer in the future. If results show a high-risk percentage, the person concerned can begin a personalised action plan, under doctors’ prescription, as part of holistic cancer management solutions.
Anu Acharya, CEO of MapmyGenome, and Dr Sunitha Lingareddy, MD of Lucid Diagnostics, announced their alliance to offer this advanced, cutting-edge, personalised, and comprehensive cancer screening at affordable rates to citizens of Hyderabad.
“Combining clinical parameters with genomics makes it very compelling for physicians and consumers to get a comprehensive screening. Genetics is an important part of clinical diagnostics and we are pleased to offer packages combining genomics and pathology lab services.”
Dr Chinthamadaka Sai Ram, clinical oncologist at MNJ Cancer Hospital, stated that it is advisable that people with a family history of cancers undergo this genetic testing, preferably after crossing 35 years of age. “Pre-test counselling and post-test counselling are very important and should be done without fail to sensitise the person on whatever may be the outcome,” he said.
Know Your Cancer Risk Before It Knows You
Oncomap by MapmyGenome offers a comprehensive hereditary cancer risk panel. Genomepatri screens for 20+ cancer types from a simple saliva swab. Both include certified genetic counselling and a CAP & NABL-accredited laboratory.
